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Impaired Mesopic Visual Acuity in Eyes with Early Age-
Related Macular Degeneration
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Amaya Clement-Corral,2 and Mar´ıa J. Pe´rez-Carrasco1
PURPOSE. To determine photopic and mesopic distance high-
contrast visual acuity (HC-VA) and low-contrast visual acuity
(LC-VA) in eyes with early age-related macular degeneration
(AMD).
METHODS. Measurements were made in 22 subjects with early
AMD and 28 healthy control subjects. Inclusion criteria
included a photopic HC-VA of 20/25 or better. Distance VA
was measured using HC (96%) and LC (10%) Bailey-Lovie
logMAR letter charts under photopic (85 cd/m2) and mesopic
(0.1–0.2 cd/m2) luminance conditions.
RESULTS. Mean mesopic distance HC-VA and LC-VA were
significantly worse (0.1 logMAR and 0.28 logMAR, respective-
ly) in the early AMD group than in the control group. Under
mesopic conditions, the mean difference between LC-VA and
HC-VA was significantly greater in the early AMD (0.45
logMAR) than the control group (0.27 logMAR). Mean
differences between mesopic versus photopic HC-VA and
mesopic versus photopic LC-VA were significantly greater in
the early AMD than the control group (0.13 and 0.32 logMAR
of difference between the means, respectively). Sensitivity and
specificity were significantly greater for mesopic LC-VA than
for mesopic HC-VA (Receiver Operating Characteristics, area
under the curve [AUC], 0.94 6 0.030 and 0.76 6 0.067,
respectively). AUC values for photopic HC-VA and LC-VA were
below 0.70.
CONCLUSIONS. Visual acuity testing under low luminance
conditions emerged as an optimal quantitative measure of
retinal function in early AMD. (Invest Ophthalmol Vis Sci.
2012;53:7310–7314) DOI:10.1167/iovs.11-8649
Age-related macular degeneration (AMD) is the leading causeof irreversible vision loss among older adults. In 2000, as
many as 1.75 million Americans showed advanced vision-
threatening stages of AMD (choroidal neovascularization
[CNV] and geographic atrophy [GA]), and many more had
asymptomatic early-stage disease.1 According to the Interna-
tional Classification and Grading System for AMD,2 the early
stage of AMD is characterized by soft drusen and changes in
retinal pigment epithelium (RPE) pigmentation associated with
soft drusen in the macular region.
Patients with AMD often complain of a worsened quality of
vision, especially difficulty in performing activities such as
reading and driving at night or in conditions of low
illumination.3–5 This loss of vision quality occurs early in the
course of AMD before any reduction in high-contrast visual
acuity (HC-VA) can be detected and before morphological
changes in the fundus become clinically apparent.5,6 In
contrast, it has been possible to correlate the more advanced
AMD stages GA and CNV with a loss in VA.7
It is known that mesopic vision testing can be sensitive to
early signs of retinal disease.8 Mesopic luminance, or dim
lighting, conditions span approximately three to four log units
(0.001–10 cd/m2) in natural viewing environments. Under
such conditions, the rod and cone photoreceptors of the
human retina simultaneously convey visual information. Rod
dysfunction or selective rod loss has been demonstrated
histologically, psychophysically, and electrophysiologically in
early AMD and aging.9–12 Also, it has been recently reported
that rod- and cone-mediated mesopic visual function is
significantly reduced in healthy persons with AMD risk
genotypes.13
Studies addressing visual function in AMD have been
extensively reviewed,6,14,15 and psychophysical tests of
vision, which depend on the functional state of the
photoreceptors, have been proposed as a strategy to assess
early AMD. In clinical settings, some of these tests are not
available, take a long time to administer, and/or are not
standardized. Among the psychophysical tests of vision,
logMAR visual acuity (VA) or Snellen charts are still the most
commonly used primary outcome measure in clinical trials
designed to address AMD.
Evidence exists to indicate that tests of photopic low-
contrast visual acuity (LC-VA) are predictors of significant
subsequent VA loss in elderly subjects with good initial visual
acuity.16,17 Although some studies have suggested that patients
with AMD show a reduction in photopic LC-VA, reports on the
usefulness of photopic LC-VA for diagnosing early AMD have
been conflicting.18–20 Few studies have centered on assessing
mesopic VA in AMD. In one such study, significantly reduced
near-letter VA was detected using the Smith-Kettlewell Low
Luminance (SKILL) card in subjects with early AMD,21 and a
relatively greater loss of distance HC-VA was detected under
low luminance conditions in eyes with GA.4 Further, the extent
of distance VA loss in low luminance conditions at baseline for
GA subjects was predictive of subsequent VA loss at 2 years.22
However, as far as we know, no study has been designed to
compare mesopic distance VA in eyes with early AMD and
control eyes, both with good photopic VA.
This study was designed to determine, using a standard
logMAR chart, whether eyes with early AMD showed impaired
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mesopic distance HC-VA and LC-VA compared to healthy eyes
that similarly had 20/25 vision or better.
METHODS
Subjects
The study was conducted at the School of Optometry, Complutense
University, Madrid, Spain. Subjects for the early AMD group were
recruited from the Hospital del Henares, Madrid. Control subjects were
relatives of those visiting the hospital or were recruited through
advertisements placed at and around the university. Fifty subjects were
enrolled, and measurements were obtained in 22 subjects with early
AMD (age range 50–77 years; mean age 64.9 6 7 years) and 28 healthy
control subjects (age range 51–78; mean age 64.6 6 7 years). Mean age
was not significantly different between the two groups. Only the right
eye of each subject was measured.
All eyes underwent a careful ophthalmologic examination, includ-
ing visual acuity, subjective refraction, slit-lamp biomicroscopy of the
anterior segment, and dilated fundoscopy and digital color photo-
graphs with a 3D OCT-1000 (Topcon Corporation, Tokyo, Japan).
Subjects were required to be older than 50 years of age, to have a best-
corrected visual acuity of 0.8 decimal (20/25 Snellen) or better in at
least one eye, a refractive error not greater than 63.75 diopters (D)
sphere or 61.50 D cylinder, and normal color vision. Exclusion criteria
were posterior subcapsular cataract; cortical or nuclear opacities
greater than LOCS III classification grade 223; diabetic retinopathy;
glaucoma; amblyopia; retinal vascular disease; or any other retinal
abnormality. Subjects were also excluded if they were aphakic or
pseudophakic or had undergone retinal surgery.
Early AMD was defined according to the International Classification
and Grading System for AMD2 as the presence of soft drusen (‡63 lm)
with or without RPE abnormalities in the form of hyperpigmentation
and/or hypopigmentation based on photographic grading and the
templates of the Age-Related Eye Disease Study (AREDS) Group.24
Control subjects were required to show no visible signs of AMD in the
tested eye (a few hard indistinct drusen <63 lm were permitted, no
RPE pigmentary alterations).
The guidelines of the Declaration of Helsinki were adhered to, and
full approval for the study was obtained from our institution’s review
board. Subjects were informed about the study protocol before giving
their consent to participate.
Visual Acuity
Best-corrected logMAR VA was measured monocularly with best
spectacle correction using high-contrast (96%) and low-contrast (10%)
Bailey-Lovie logMAR letter charts under both photopic (85 cd/m2) and
mesopic (0.1–0.2 cd/m2) luminance conditions at a distance of 4
meters. Subjects were forced to guess letters even if they were unsure.
Each letter read correctly on each line was given a score of 0.02 log
units. In this chart, a loss of one line of letters corresponds to a logMAR
increase of 0.1. The Bailey-Lovie chart is a valid, reliable, and rapid
method of measuring threshold visual acuity for research purposes,25
and HC-VA and LC-VA acuity have been shown to be repeatable. In
previous studies the repeatability coefficient (1.96 SD) was 0.07 to 0.1
logMAR or one line for the HC (90%) chart.26–28 The limits of
agreement increased to approximately 60.15 logMAR for the LC (10%)
chart.26,29 Under dim illumination conditions, Applegate et al.
recommended mesopic LC-VA as a sensitive clinically viable measure
of visual performance in healthy eyes.30
The chart was externally illuminated with a halogen lamp behind a
screen connected to a potentiometer to adjust the exact voltage
needed to reach the adequate mesopic luminance level with the room
lighting turned off. This setup provides uniform luminance over the
chart. For photopic conditions, normal room lighting was left on. In
both cases, measures of luminance for the tests were obtained using a
MAVO-SPOT 2 USB luminance meter (Gossen Lighting Control,
Nuremberg, Germany). The subject was first tested under mesopic
conditions; at least 10 minutes was allowed to dark adapt before the
test. After this procedure, acuity testing was continued at photopic
luminance levels.
Statistical Analysis
Visual acuity measurements were analyzed by mixed model ANOVA
with one between-subjects factor (group [early AMD versus control])
and two within-subjects factors (luminance condition [mesopic versus
photopic] and contrast [low versus high]). When interaction effects
were significant, the data were then split by each factor, and Student’s
t-test used to test the difference between the means. A P value less than
0.05 was taken to denote statistical significance. Statistical analysis was
performed using SPSS Statistics 19 for Windows (SPSS Inc., IBM,
Somers, NY).
The diagnostic value of each test was assessed by the area under the
curve (AUC) of a Receiver Operating Characteristic (ROC) analysis as a
plot of the sensitivity for AMD visual function abnormality against the
false alarm rate (1  specificity). We defined a test as valid when the
AUC was >0.70.31 The v2 test was used to compare the AUCs. These
analyses were performed using SigmaPlot 11 software (Systat Software,
Inc., Chicago, IL).
RESULTS
Table 1 provides the mean values of photopic best-corrected
HC-VA and LC-VA (logMAR) and mean mesopic HC-VA and LC-
VA (logMAR) recorded in the early AMD and control groups.
Mixed ANOVA showed a main effect of the presence of early
AMD (F ¼ 12.95; P ¼ 0.001) and main effects of contrast (F ¼
1659.24; P < 0.0001) and luminance condition (F¼ 1045.35; P
< 0.0001). Significant interactions were detected between
contrast and group (F ¼ 42.79; P < 0.0001); luminance
condition and group (F ¼ 46.73; P < 0.0001); luminance
condition and contrast (F ¼ 102.65; P < 0.0001); and group,
contrast, and luminance condition (F ¼ 28.01; P < 0.0001).
Interaction effects were examined using Student’s t-test. Under
photopic conditions, means for HC-VA and LC-VA did not vary
significantly between the early AMD and control groups. In
contrast, under mesopic conditions, the AMD group showed
worse VA at both high and low contrast. Mean mesopic HC-VA
was 0.1 logMAR (one line of letters on the chart) worse in the
AMD group than in the control group (P¼ 0.002), while mean
mesopic LC-VA was 0.28 logMAR (nearly three lines of VA)
worse (P < 0.0001) in the AMD group than the control group.
Figure 1 shows the mean differences in logMAR units
recorded between LC-VA and HC-VA measured at both
luminance levels in the two groups of eyes. While the mean
differences in VA were similar for the two groups under
photopic conditions (P ¼ 0.82), our mesopic measurements
revealed a difference between mean LC-VA and HC-VA of 0.45
6 0.06 logMAR (4.5 lines of VA) for the AMD group and of 0.27
6 0.06 logMAR (2.7 lines) for the control group, that is, nearly
two lines of difference (0.18 logMAR) between the mesopic
means of the two groups (P < 0.0001).
TABLE 1. Distance High-Contrast (HC) and Low-Contrast (LC) Visual
Acuity Means (logMAR VA) Recorded in Photopic and Mesopic
Luminance Conditions in the Early AMD and Control Groups
Group
Photopic logMAR VA Mesopic logMAR VA
HC LC HC LC
Early AMD 0.03 6 0.07 0.24 6 0.12 0.55 6 0.12 1.00 6 0.11
Control 0.06 6 0.05 0.26 6 0.11 0.44 6 0.11 0.72 6 0.13
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Figure 2 shows the mean differences in logMAR units
detected between mesopic and photopic VA in both high- and
low-contrast tests in the AMD and control groups. The mean
drop in HC-VA observed under mesopic compared to photopic
conditions was 5.1 lines (a 0.51 logMAR increase from 0.55
[mesopic] to 0.03 [photopic]) in the AMD group and 3.8 lines
(0.38 logMAR) in the control group, that is, 1.3 lines (0.13
logMAR) of difference between the means of the two groups (P
< 0.0001). For LC-VA, the mean difference observed when
photopic with mesopic conditions were compared was 7.6
lines (0.76 logMAR) in the early AMD group and 4.4 lines (0.44
logMAR) in the control group, that is, 3.2 lines of difference
(0.32 logMAR) between the means of the two groups (P <
0.0001).
In the ROC analyses (Table 2), the AUC for photopic HC-VA
and LC-VA was below the 0.70 value, indicating no diagnostic
capacity. Mesopic LC-VA yielded the highest AUC value (0.94 6
0.030), indicating a lower false alarm rate, the difference with
the mesopic HC-VA AUC (0.76 6 0.067) being statistically
significant (P ¼ 0.0001). Comparable AUC values were found
between mesopic LC-VA (0.94 6 0.030) versus VA difference
(mesopic LC-VA photopic LC-VA) (0.96 6 0.028) (P¼ 0.389)
and mesopic LC-VA (0.94 6 0.030) versus VA difference
(mesopic LC-VAmesopic HC-VA) (0.96 6 0.027) (P¼ 0.625).
Table 3 shows sensitivity and specificity values for ROC curves
with AUC values higher than 0.70. These measurements
emerged as sensitive and specific for detecting early AMD-
related functional abnormality.
DISCUSSION
The findings of our study indicate impaired mesopic best-
corrected distance HC-VA and LC-VA in eyes with early AMD
compared to healthy control eyes. Under photopic conditions,
both mean HC-VA and LC-VA did not vary significantly between
the early AMD and control groups. It should be noted that all
eyes had a photopic distance HC-VA of 20/25 or better so that
confounding effects could be avoided. Other studies have
shown reductions of a few letters in distance photopic LC-VA
in AMD patients,18 and Lovie-Kitchin19 and Abadi and
Pantazidou20 concluded that while photopic LC-VA was
reduced in AMD, its measurement gave no additional
information over that provided by HC-VA. In these studies,
the AMD eyes already had slightly reduced HC-VA; thus this
conclusion is logical.
While photopic HC-VA measurement is inadequate for the
assessment of functional deficits in early AMD17 or for
monitoring progression of the disorder,32 according to our
results, VA measures under mesopic luminance conditions
could be useful. We found that mean distance HC-VA and LC-VA
were one line and 2.8 lines of letters worse, respectively, in the
early AMD group than in the control group (Table 1). Also, in
mesopic conditions the difference between LC-VA and HC-VA
was significantly greater in the early AMD group—1.8 lines on
average more than in the control group (Fig. 1). Only a few
studies have examined VA under low luminance conditions in
early AMD subjects. Feigl et al. recorded significantly reduced
SKILL scores (difference in number of letters between the dark
and light sides of the card) using the SKILL card33 in people
with early AMD (and an HC-VA of 6/12 or better).21 It should
be noted that the test was conducted at near distance under
normal room lighting conditions and that the early AMD
subjects examined already had slightly reduced HC-VA. In eyes
with GA, a relatively greater loss of distance HC-VA (4.6 lines)
was detected when compared to eyes with drusen (2.2 lines),
that is, 2.4 lines of difference, under low luminance conditions
obtained using a neutral density filter.4 Our mesopic condition
was one of very low luminance, and the mean HC-VA drop
FIGURE 1. Mean difference between the HC-VA and the LC-VA
measurements made under photopic or mesopic luminance conditions
in the early AMD and control groups. Mean VA differences are plotted
as logarithms of the minimum angle of resolution (logMAR units) on
the left y-axis and as numbers of lines on the chart on the right y-axis.
**P < 0.01.
FIGURE 2. Mean difference between the mesopic and photopic VA
measurements made using both high- and low-contrast letter charts in
the early AMD and control groups. Mean visual acuity differences are
plotted as logarithms of the minimum angle of resolution (logMAR
units) on the left y-axis and as numbers of lines on the chart on the
right y-axis. **P < 0.01.
TABLE 2. ROC Analyses of Photopic and Mesopic High-Contrast (HC) and Low-Contrast (LC) VA and for Differences between Them
VA Parameters AUC 6 SD VA Difference Parameters AUC 6 SD
Photopic HC-VA 0.67 6 0.084 Photopic LC-VA  photopic HC-VA 0.50 6 0.087
Photopic LC-VA 0.63 6 0.083 Mesopic HC-VA  photopic HC-VA 0.81 6 0.060
Mesopic HC-VA 0.76 6 0.067 Mesopic LC-VA  photopic LC-VA 0.96 6 0.028
Mesopic LC-VA 0.94 6 0.030 Mesopic LC-VA  mesopic HC-VA 0.96 6 0.027
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observed was 5.1 lines for eyes with early AMD versus 3.8 lines
for control eyes, that is, 1.3 lines of difference between the
means of the two groups. The mean LC-VA drop (between
mesopic and photopic) was 3.2 lines more for the early AMD
group compared to the control group (Fig. 2). These results
indicate adversely affected VA under mesopic conditions in
eyes with early AMD. It should be noted that in our study,
measuring VA under low luminance conditions showed a good
capacity to quantify functional abnormalities in eyes affected
by early AMD; AUC values in the ROC analyses ranged from
0.76 6 0.067 to 0.96 6 0.027 (Table 2) and showed a
significantly greater diagnostic capacity than the universally
used measure of photopic HC-VA. These significant functional
abnormalities were present despite the majority of participants
having a photopic HC-VA of 20/25 or better.
Psychophysical studies have demonstrated that rod- and
cone-mediated mesopic visual function deteriorates in the early
stages of AMD.6 Mesopic VA is probably a better reflection of
the role played by cone foveal function than by rod function
under reduced illumination given the paucity of rods in the
foveal region. It is still not clear whether functional deficits in
early AMD measured using various psychophysical tests are
primarily caused by a reduced sensitivity of photoreceptors, by
postreceptor damage, or by damage to other tissues involved in
AMD such as the RPE/Bruch’s membrane complex or the
choroid. Feigl et al.34 reviewed this issue, and based on their
psychophysical and electrophysiological findings proposed
that most function impairment in early AMD starts postrecep-
torally. For the purpose of our study, the so-called ischemia
postreceptoral hypothesis could explain why mesopic VA is
reduced in early AMD when the cones and photopic VA are still
preserved.
The mesopic distance VA impairment detected in our study
indicates that VA assessment using logMAR charts in low
luminance conditions is a sensitive indicator of impaired
macular function in the early stages of AMD before any
photopic HC-VA alterations occur. This simple, inexpensive,
and rapid measure of visual function could be especially useful
for the early detection of AMD.
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